Ljubica Spasic
Ljubica Spasic has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Dejan Aleksandric
Institute for Orthopedic Surgery “Banjica”, 11000 Belgrade, Serbia
1 shared publication - Dunja Savicevic
Special Hospital for Rehabilitation and Orthopedic Prosthetics, 11000 Belgrade, Serbia
1 shared publication - Jovana Grupkovic
Clinic for Orthopedic Surgery and Traumatology, University Clinical Center of Serbia, 11000 Belgrade, Serbia
1 shared publication - Nikola Bogosavljevic
Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia
1 shared publication - Slavisa Zagorac
Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia
1 shared publication - Uros Dabetic
Clinic for Orthopedic Surgery and Traumatology, University Clinical Center of Serbia, 11000 Belgrade, Serbia
1 shared publication
Latest Publications
- Open Access
- 27 June 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (7) , 1575
Targeted Interventional Therapies for the Management of Postamputation Pain: A Comprehensive Review
Postamputation pain (PAP), including residual limb pain (RLP) and phantom limb pain (PLP), remains a significant and debilitating complication after limb loss. Despite advances in pharmacological management, many patients experience inadequate pain relief, underscoring the need for alternative therapeutic strategies. Objective: This narrative review critically synthesizes current interventional therapies for PAP, focusing on mechanisms, clinical efficacy and practical application. Methods: A literature search was conducted in PubMed, EMBASE, Scopus and Web of Science databases for studies published between 2015 and 2025. Relevant articles on peripheral nerve interventions as well as different neuromodulation techniques were included. Results: Peripheral interventions (such as alcohol neurolysis, radiofrequency ablation (RFA) and cryoneurolysis (CNL)) and neuromodulation techniques (including spinal cord stimulation (SCS), dorsal root ganglion (DRG) stimulation and cauda equina stimulation (CES)) demonstrate promising outcomes for PAP. Peripheral nerve stimulation (PNS) shows favorable safety and efficacy profiles and may help prevent the chronification of pain. Conclusions: Contemporary interventional therapies represent valuable options in the multidisciplinary management of PAP. Nevertheless, further research is required to standardize clinical algorithms, optimize therapeutic decision-making and improve long-term outcomes and quality of life for individuals with PAP.
- 27 June 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (7) , 1575
Open AccessTargeted Interventional Therapies for the Management of Postamputation Pain: A Comprehensive Review
Postamputation pain (PAP), including residual limb pain (RLP) and phantom limb pain (PLP), remains a significant and debilitating complication after limb loss. Despite advances in pharmacological management, many patients experience inadequate pain relief, underscoring the need for alternative therapeutic strategies. Objective: This narrative review critically synthesizes current interventional therapies for PAP, focusing on mechanisms, clinical efficacy and practical application. Methods: A literature search was conducted in PubMed, EMBASE, Scopus and Web of Science databases for studies published between 2015 and 2025. Relevant articles on peripheral nerve interventions as well as different neuromodulation techniques were included. Results: Peripheral interventions (such as alcohol neurolysis, radiofrequency ablation (RFA) and cryoneurolysis (CNL)) and neuromodulation techniques (including spinal cord stimulation (SCS), dorsal root ganglion (DRG) stimulation and cauda equina stimulation (CES)) demonstrate promising outcomes for PAP. Peripheral nerve stimulation (PNS) shows favorable safety and efficacy profiles and may help prevent the chronification of pain. Conclusions: Contemporary interventional therapies represent valuable options in the multidisciplinary management of PAP. Nevertheless, further research is required to standardize clinical algorithms, optimize therapeutic decision-making and improve long-term outcomes and quality of life for individuals with PAP.